The results of qRT PCR analysis suggested lower serum lncRNA GAS5 levels in CHB patients, and the results of ROC curve analysis showed that serum lncRNA GAS5 could effectively differentiate between CHB liver fibrosis patients and healthy controls (AUC of 0.993, 0.972–0.992). The gene discussed is GAS5; the disease is Hepatic fibrosis.